Merck asks EU regulators to authorize its COVID-19 pills

Amsterdam (Associated Press)- European Medicines Agency Said it received from Merck Authorizes its coronavirus antiviral drug, which is the first pill to treat COVID-19.

In a statement on Tuesday, I The drug regulatory agency stated that it has begun to evaluate Merck And Ridgeback Biotherapeutics, and a decision can be made within a few weeks on whether it can be eliminated.

Last week, the EMA issued an emergency recommendation stating that monupiravir can be used to treat adults infected with the coronavirus. These adults do not need extra oxygen and are at increased risk of serious illness.

The agency stated that the drug should be given as soon as possible after the diagnosis of COVID-19 and within five days of the onset of symptoms. It is intended to be taken twice a day for five days.

Earlier this month, the United Kingdom became the first country in the world to approve this drug. The UK has approved monupivir for adults who have been diagnosed with COVID-19 and have at least one risk factor for serious illness.

An antiviral pill that reduces symptoms and speeds up recovery may be groundbreaking. It can reduce the burden of cases in hospitals, and combined with vaccination campaigns, can help curb outbreaks.

Europe is now at the center of the pandemic, and the World Health Organization warned that if emergency measures are not taken, 700,000 people in Europe may die from COVID-19 by the spring.

Molnupiravir is also awaiting review by US regulators and is expected to convene a panel of experts to consider authorization later this month.

Even if the pills are approved, the initial supply will be limited. Merck It was said that 10 million treatment courses could be produced this year, but most of the supplies have been purchased by governments around the world.

In October, Merck It agreed to let other drugmakers produce monelavir, and signed a license agreement with the United Nations-supported drug patent pool, allowing companies in dozens of countries to produce its pills.

Copyright © 2021 The Washington Times, LLC.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *